Pure Global
NCT05441696

Study for the Evaluation of a Non-invasive Hemodynamic Measurement in Heart Failure Patients

Pilot Study for the Evaluation of ezCVP in Heart Failure Patients
Nihon Kohden·ClinicalTrials.gov·device·Device trialEnrolling by invitation
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Congestive Heart Failure
Drug/Device/Intervention
ezCVP measurement
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Nihon Kohden
Location
Palo Alto,Stanford, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2022
End date
May 30, 2024
Enrollment
65 participants
Primary outcome

Evaluate the difference between non-invasive CVP measurement at admission and at discharge,Evaluate the difference between non-invasive CVP measurement in right and left arms

Summary

Track changes in non-invasive central venous pressure across hospital stay and relationship
 with readmission

ICD-10 classifications
Congestive heart failureHeart failureHypertensive heart disease with (congestive) heart failureHypertensive heart and renal disease with (congestive) heart failureHeart failure, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05441696
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05441696 through Pure Global AI's free database. This phase not specified trial is sponsored by Nihon Kohden and is currently Enrolling by invitation. The study focuses on Congestive Heart Failure. Target enrollment is 65 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.